You searched for: c1-esterase inhibitors

5931 results

Specialised immunology and allergy services

This Lead and Inform Clinical Reference Group (CRG) covers specialised treatment of certain immunological and allergic conditions. Scope This clinical reference group covers: Immunological conditions including: primary immunodeficiencies autoimmune and autoinflammatory disease where there is associated immunodeficiency complex autoimmune and vasculitic conditions autoinflammatory syndromes Allergic conditions including severe, complex and/or rare sub-groups. Membership Dr Claire […]

Interim Clinical Commissioning Policy: IL-6 inhibitors (tocilizumab or sarilumab) for hospitalised patients with COVID-19 (adults)

Rapid policy statement Publications approval reference: C1712 Contents Commissioning position Evidence and policy summary Implementation Governance Equality statement Definitions References Publication date: 28 November 2022 Effective from: 28 November 2022 Commissioning position Tocilizumab is recommended to be available as a treatment option through routine commissioning for adult patients (aged 18 years and older) hospitalised with […]

COVID-19 Therapeutics (antivirals, neutralising monoclonal antibodies and interleukin 6 inhibitors)

This section contains information on the total number of COVID-19 therapeutics (antivirals – ‘AVs’, neutralising monoclonal antibodies – ‘nMABS’, and interleukin 6 – ‘IL-6’ inhibitors) provided by the NHS in England to: Eligible individuals hospitalised due to COVID-19, or with hospital-onset COVID-19 in England. Eligible non-hospitalised individuals in England with COVID-19 since AVs and nMABs […]

Updated JCVI guidance for vaccinating immunosuppressed individuals with a third primary dose

Contents Actions now required Annex A – JCVI list of eligible individuals Annex B: Template letter to severely immunosuppressed individuals for GP practices and consultants to adapt and issue Annex C – Template letter for consultants (to be put on consultant / GP letterhead)   Classification: Official Publication approval reference: C1399 To: All GP practices […]

Assuring implementation of JCVI guidance for vaccinating immunosuppressed individuals with a third primary dose

Contents Immediate action required Annex A – JCVI List of eligible individuals   Classification: Official Publication approval reference: C1428 To: All NHS trust and foundation trust chief executives All NHS trust and foundation trust medical directors CC: CCG accountable officers ICS leads PCN-led vaccination sites Regional Directors Regional Directors of Commissioning   Dear colleague On […]